Autonomix Medical, Inc.
AMIX· Nasdaq
Released Feb 11, 2026, after the close
10-Q filed Feb 11, 2026, 42 days after period end · 0001437749-26-003816
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2026 | Q3 2025 | Q3 2024 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | — |
| Net Income | -$3.26M | -$2.71M | -$3.11M | -$544.00K |
| EPS Diluted | — | — | -$0.23 | -$0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Autonomix Medical, Inc. · CIK 1617867 · Engraved from SEC EDGAR